Le Lézard
Classified in: Health
Subject: CSR

Massage Envy Announces Policy Changes Following Recent Allegations


SCOTTSDALE, Ariz., Dec. 5, 2017 /PRNewswire/ -- Massage Envy announces six-point plan and revises its policies in response to recent sexual assault allegations. Massage Envy CEO Joe Magnacca released the following letter on December 5, 2017:

Massage Envy

Throughout Massage Envy's 15-year history, safety in the treatment room has been - and always will be - paramount. The recent, heartbreaking stories of sexual assault suffered in Massage Envy franchise locations caused us to take a hard look at our business and at how we protect the members and guests who have placed their trust in the brand.

Last week, we shared the first steps that we have taken. Today, we're announcing a six-point plan, to drive additional, meaningful change. This plan will be rolled out and implemented across the network over the coming weeks.

 Massage Envy Commitment to Safety:

We believe the work we're doing today can serve as a solid foundation for change across the industry, and we're working with industry groups - like the American Massage Therapy Association - to move that conversation forward.

The safety and well-being of members and guests has been our mission from day one and our commitment has never been stronger. We know that you put your trust in the brand, and we will keep working to earn it.

Contact:

Lynne Boschee
[email protected]

 

SOURCE Massage Envy


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: